The experience of UK patients with bladder cancer during the COVID-19 pandemic: a survey-based snapshot
BJU Int
.
2021 Feb;127(2):179-181.
doi: 10.1111/bju.15287.
Epub 2020 Nov 16.
Authors
Sarah Spencer-Bowdage
1
,
Beth Russell
2
,
Jeannie Rigby
1
,
Jackie O'Kelly
1
,
Phil Kelly
1
,
Mark Page
1
,
Caroline Raw
1
,
Paula Allchorne
1
3
,
Peter Harper
1
4
,
Jeremy Crew
1
5
,
Roger Kockelbergh
1
6
7
,
Allen Knight
1
8
,
Mieke Van Hemelrijck
2
,
Richard T Bryan
1
9
Affiliations
1
Action Bladder Cancer UK, Tetbury, UK.
2
Translational Oncology and Urology Research, King's College London, London, UK.
3
Barts Health NHS Trust, London, UK.
4
Leaders in Oncology Care, London, UK.
5
Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
6
University Hospitals of Leicester NHS Trust, Leicester, UK.
7
Leicester Cancer Research Centre, University of Leicester, Leicester, UK.
8
World Bladder Cancer Patient Coalition, Brussels, Belgium.
9
Bladder Cancer Research Centre, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
PMID:
33124729
PMCID:
PMC7894556
DOI:
10.1111/bju.15287
No abstract available
MeSH terms
COVID-19*
Delivery of Health Care*
Humans
Self Report
United Kingdom
Urinary Bladder Neoplasms / therapy*